Montville, NJ, United States of America

Sung James Lee

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 131(Granted Patents)


Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Sung James Lee: An Innovative Mind in ADHD Treatment

Introduction:

Sung James Lee, an esteemed inventor based in Montville, NJ, has made significant contributions to the field of attention-deficit/hyperactivity disorder (ADHD) treatment. With a total of 9 patents under his belt, Lee has been at the forefront of developing methods for effectively managing this neurological condition. This article will highlight Sung James Lee's most recent patents related to ADHD treatment and shed light on his professional association with SK Biopharmaceuticals Co., Ltd.

Lee's Latest Patents:

Sung James Lee's innovative patents focus on methods for treating attention-deficit/hyperactivity disorder (ADHD) and have been making waves in the medical community. His most recent inventions involve administering a therapeutically effective amount of a carbamoyl compound or its pharmaceutically acceptable salt to subjects with ADHD. By exploring new avenues in ADHD treatment, Sung James Lee is actively contributing to the wellbeing and quality of life of individuals affected by this condition.

Professional Association:

Sung James Lee is a valued employee of SK Biopharmaceuticals Co., Ltd., a reputable company known for its contributions to the pharmaceutical industry. By working with SK Biopharmaceuticals, Lee has access to state-of-the-art facilities, research resources, and a team of skilled professionals. Capitalizing on this collaborative environment, Lee can channel his innovative ideas and inventive spirit towards enhancing ADHD treatment options.

Collaborative Efforts with Susan Marie Melnick:

Within SK Biopharmaceuticals, Sung James Lee works closely with his colleague, Susan Marie Melnick. Collaborative efforts often yield fruitful results, and this partnership is no exception. Susan Marie Melnick's specific role and contributions in the ADHD treatment research remain undisclosed, but it can be inferred that their expertise and cooperation have been instrumental in advancing the field.

Conclusion:

Sung James Lee's dedication to the development of novel methods for treating attention-deficit/hyperactivity disorder (ADHD) showcases his commitment to improving the lives of those affected by this condition. With his work at SK Biopharmaceuticals Co., Ltd., Lee has the resources and support necessary to continue making innovative strides in ADHD treatment. Through continued research and collaboration, it is evident that Sung James Lee and Susan Marie Melnick are pushing the boundaries of scientific and medical advancements, ultimately bringing hope to individuals diagnosed with ADHD.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…